Nektar Therapeutics (NKTR) Stock Price

NKTRStock
$74.96+172.62%52W
Market Cap$2.56B
P/E
PEG Ratio0.31
Div yield
Beta1.23

NKTR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-10.55%
Price vs S&P 500 (4W)1.07%
PEG Ratio0.31
VGM Score48.44

NKTR Earnings Surprise History

Q2 25-2.78est. -3.12
Q3 25-1.87est. -2.79
Q4 25-1.29est. -3.50
Q1 26-1.78est. -1.48
Q2 26-1.21est. -2.04

NKTR Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.31
4.31
4.31
4.29

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NKTRNektar Therapeutics
CDB$74.96
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company developing immunotherapy medicines in clinical development. Its pipeline includes REZPEG (NKTR-358), NKTR-422, NKTR-0165, and NKTR-255, among other candidates. The company focuses on discovering and developing novel therapeutics to address unmet medical needs in immunology.